ɐkˈoːɹdɪŋ tə lˈændʒ, hˌuː sˈɜːvd æz pɹˈɪnsɪpəl ɪnvˈɛstᵻɡˌeɪɾɚ, ðiːz fˈaɪndɪŋz "klˈɪɹli dˈɛmənstɹˌeɪt ðə kˈɑːmpɚɹəbəl ˈɛfɪkəsi ʌv nˈɛvɚɹˌæpaɪn ænd ˈɛfɐvˌaɪɚnts ɪn ˌeɪtʃˌaɪvˈiː tɹˈiːtmənt".
According to Lange, who served as principal investigator, these findings "clearly demonstrate the comparable efficacy of nevirapine and efavirenz in HIV treatment".